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Abstract
Background: With an aging society and raised expectations, joint replacement surgery is likely to increase significantly
in the future. The development of postoperative complications following joint replacement surgery (for example,
infection, systemic inflammatory response syndrome and deep vein thrombosis) is also likely to increase. Despite
considerable progress in orthopaedic surgery, comparing a range of biological markers with the ultimate aim of
monitoring or predicting postoperative complications has not yet been extensively researched. The aim of this clinical
pilot study was to test the hypothesis that lower limb orthopaedic surgery results in changes to coagulation,
non-specific markers of inflammation (primary objective) and selective clinical outcome measures (secondary objective).
Methods: Test subjects were scheduled for elective total hip replacement (THR) or total knee replacement (TKR)
orthopaedic surgery due to osteoarthritis (n = 10). Platelet counts and D-dimer concentrations were measured to assess
any changes to coagulation function. C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) were measured
as markers of non-specific inflammation. Patients were monitored regularly to assess for any signs of postoperative
complications, including blood transfusions, oedema (knee swelling), wound infection, pain and fever.
Results: THR and TKR orthopaedic surgery resulted in similar changes of coagulation and non-specific inflammatory
biomarkers, suggestive of increased coagulation and inflammatory reactions postoperatively. Specifically, THR and TKR
surgery resulted in an increase in platelet (P = 0.013, THR) and D-dimer (P = 0.009, TKR) concentrations. Evidence of
increased inflammation was demonstrated by an increase in CRP and ESR (P≤ 0.05, THR and TKR). Four patients received
blood transfusions (two THR and two TKR patients), with maximal oedema, pain and aural temperatures peaking between
days 1 and 3 postoperatively, for both THR and TKR surgery. None of the patients developed postoperative infections.
Conclusions: The most noticeable changes in biological markers occur during days 1 to 3 postoperatively for both THR
and TKR surgery, and these may have an effect on such postoperative clinical outcomes as oedema, pyrexia and pain.
This study may assist in understanding the postoperative course following lower limb orthopaedic surgery, and may help
clinicians in planning postoperative management and patient care.
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Background
In 2012, the National Joint Register (UK) recorded that
80,314 hip and 84,653 knee replacement (arthroplasty)
procedures were undertaken across the country. More
than 93% of these procedures were undertaken as a result
of osteoarthritis [1].
With an aging society and the raised expectations of our
population, joint replacement surgery is likely to increase
significantly during the next few years. In an article recently
published by Frampton [2], it is estimated that by the year
2030, hip replacement will increase by 157%, while knee re-
placement will increase by 673%. As a result, it can be appre-
ciated that the development of postoperative complications
following joint replacement surgery (for example, infection,
systemic inflammatory response syndrome, deep vein
thrombosis or haemorrhaging) is likely to increase. Despite
considerable progress in the field of orthopaedic surgery,
comparing a range of biological markers with the ultimate
aim of monitoring or predicting postoperative complications
has not yet been extensively researched.
Conventionally in the UK, patients are monitored dur-
ing the postoperative period by means of a full blood
count and urea and electrolytes tests. These tests cannot
predict outcome or monitor patients during the postoper-
ative course. However, little evidence is available to dem-
onstrate the effects of lower limb orthopaedic surgery on
selective coagulation and inflammatory biomarkers, in-
cluding various clinical outcome measures.
Changes in leucocyte subpopulations have previously
been studied in patients undergoing THR surgery. Specific-
ally, this study involved 12 patients and found leucocytosis,
monocytosis, lymphocytopenia and granulocytosis after
surgery [3]. It can be appreciated that platelets play a key
role during primary haemostasis and aid in the de-
velopment of blood clotting. Although increased platelet
counts have been reported to be dominant contributors to
hypercoagulability after injury in surgical intensive care
trauma patients, little evidence has been documented with
respect to changes in platelet concentrations following
lower limb orthopaedic surgery [4]. With regards to the co-
agulation pathway, fibrin degradation products are formed
whenever fibrin is broken down by enzymes (for example,
plasmin). D-dimer is an end product derived from
plasmin-mediated degradation of cross-linked fibrin clots.
D-dimer measurement has proved to be a sensitive marker
for the evaluation of disseminated intravascular coagulation
(DIC) [5]. In addition, low levels of D-dimer can effectively
rule out those patients with a low or a moderate probability
of venous thromboembolism, such as deep vein thrombosis
or pulmonary embolism [6,7].
C-reactive protein (CRP) is produced in the liver and is a
member of the class of acute-phase reactants as its levels
rise dramatically during inflammatory processes occurring
in the body. The erythrocyte sedimentation rate (ESR)
measures the rate at which the red blood cells separate
from the plasma. During an inflammatory process, the high
proportion of fibrinogen in the blood causes red blood cells
to stick to each other. The red cells form stacks, called
‘rouleaux’, which settle more quickly. Margheritini et al. [8]
performed a study to establish normal values for the ESR
and CRP levels after uncomplicated anterior cruciate liga-
ment reconstruction. This investigation involved measure-
ment of ESR and CRP in 45 consecutively treated patients.
Blood samples were collected before surgery and on post-
operative days 1, 3, 7, 15 and 30. Results from the study
demonstrated that both ESR and CRP levels showed a
marked increase postoperatively, peaking between the third
and seventh postoperative days, with the latter showing a
faster return to normal. Findings from this study proposed
that measurement of CRP can be used as a more accurate
predictor than ESR of postoperative complications. Our
study aims to build on previous work and, specifically, to
evaluate changes to CRP and ESR values following THR
and TKR surgery.
Previous studies have demonstrated the effect of various
orthopaedic interventions on surgical complications [9-13].
Despite considerable progress in the field of orthopaedic
surgery, surgical complications still exist. Every operation
carries a wide range of risks from the most insignificant
(for example, low volume blood loss) to the most serious,
such as development of deep vein thrombosis, infection
and systemic inflammatory response syndrome (including
fatal complications). The aim of this study was to test the
hypothesis that lower limb orthopaedic surgery results in
changes to coagulation, non-specific markers of inflam-
mation (primary objective) and selective clinical outcome
measures (secondary objective). It is anticipated that any
changes in the measured parameters may provide future
direction with respect to therapeutic intervention, which
may have an important impact with regards to treatment
strategies following orthopaedic trauma.
Methods
Subject volunteers
Ethical approval for this pilot study was received from the
local research ethics committee (North Wales Central Re-
search Ethics Committee, reference number 05/WNo02/26).
Ten volunteers scheduled for either elective THR or TKR
surgery were recruited with their informed consent. The test
subjects were aged between 58 and 87 years old (mean
age = 77 for both THR and TKR), and were all scheduled for
elective surgery due to osteoarthritis. Five patients were
scheduled for THR (three women and two men) and five pa-
tients for TKR (three women and two men).
Blood samples
Venous blood samples were collected by venepuncture and
collected into vacutainers containing EDTA-K2, sodium
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citrate and serum clot activator (Greiner Bio-one, UK).
Plasma was obtained by centrifuging whole blood samples
at 450g for 15 minutes, following which all plasma samples
were used for the D-dimer assays.
Total hip replacement surgery
Prior to surgery, an 18GA cannula (BD Venflon™, Sweden)
was inserted into the arm at the antecubital fossa. A ven-
ous blood sample was then collected preoperatively,
which stood as a baseline measurement for that particular
patient. In theatre, patients were prepared for THR sur-
gery by undergoing general anaesthesia. Blood samples
were then collected from the arm by means of the cannula
following surgery at day 1, 3 and 5 postoperatively. No
tourniquet was used during this orthopaedic surgical pro-
cedure, although to maintain a bloodless field during sur-
gery, methods such as ligation (clamping and tying off
blood vessels) and/or diathermy (heat probe that hyper-
coagulates the blood vessels) were employed.
Total knee replacement surgery
Prior to surgery an 18GA cannula (BD Venflon™, Sweden)
was inserted into the arm at the antecubital fossa. A ven-
ous blood sample was collected preoperatively, which
stood as a baseline measurement for that particular
patient. In theatre, patients were prepared for TKR by ad-
ministering general anaesthesia. Before commencing sur-
gery, a tourniquet was set around the upper thigh and
inflated to 315 ± 9.80 mmHg, to ensure a bloodless field
prior to surgery. The mean time of ischaemia was 94 ±
7.47 minutes per TKR surgical procedure. Blood samples
were collected from the arm by means of the cannula
upon the release of the tourniquet at 5 and 15 minutes re-
perfusion, and on days 1, 3 and 5 postoperatively.
Measurement of platelet concentration
Following venepuncture, total platelet counts were
performed using a Coulter® MicroDiff18 blood analyzer
(Beckman Coulter, UK).
Measurement of D-dimer concentration
Levels of the D-dimer parameter were measured using a
Mini-Vidas automated immunoassay system that uses
enzyme-linked fluorescent assay technology. The Mini-
Vidas system and immunoassay kits were obtained from
Biomerieux, UK.
Measurement of C-reactive protein
Highly sensitive CRP measurement was achieved using the
Quantex CRP plus kits (Bio-kit, Spain) and involved using
a turbidimetric assay as described by Price et al. [14].
Measurement was then performed using an ILAB 600 clin-
ical chemistry analyzer (Instrumentation Laboratory, UK).
Measurement of erythrocyte sedimentation rate
During this study, the Westergren method was employed
using kits and racks supplied by Becton Dickinson, UK.
The ESR is the rate at which the red blood cells separate
from the plasma and fall to the bottom of the tube. The
amount of sedimentation was noted after 1 hour, to pro-
vide the rate in mm/hr [15].
Clinical outcome measures
Patients were monitored regularly during the postopera-
tive course to assess for any signs of complication, which
included: blood transfusion (the number of ABO/rhesus
compatible red cell units); oedema (knee swelling was
determined by measuring girth size 10 cm from the
tibial tuberosity, the bony prominence on the upper
shinbone (tibia), for the TKR surgery study only); Post-
operative pain (pain was scored using a point scoring
system with 1 indicating no pain; 2, mild pain; 3, moder-
ate pain and 4, severe pain); pyrexia or fever (monitored
by measurement of aural (ear) temperatures, with a fever
being diagnosed when the temperature was at, or higher
than, 37.5°C); infection (wound swabs collected at various
time points and incubated for 48 hours on various micro-
biology plates that included: blood agar, MacConkey agar,
an anaerobic medium, and agar selective for Staphylococ-
cus and Streptococcus.
Statistical analysis
During this study, all results were presented as either
mean or median ± standard deviation (SD). Where data
were normally distributed, a repeated measures one-way
analysis of variance (ANOVA) between-samples test was
employed, adopting a 5% level of significance. Post hoc
testing was conducted using Tukey’s test for pairwise com-
parisons between means. Data that did not comply with
normality were analyzed using the Friedman test. Where
the Friedman test resulted in statistical significance, subse-
quent tests were performed using the Wilcoxon test. Stat-
istical significance was accepted for P ≤ 0.05.
Results
Effect of total hip replacement and total knee replacement
surgery on coagulation biomarkers
Platelet count
This parameter was measured as a marker of coagulation
activity. With regards to the platelet counts and THR
(Figure 1), these decreased from baseline (288 ± 54.87), dur-
ing day 1 (225 ± 27.15) and day 3 (218 ± 32.0) postopera-
tively. By day 5 postoperatively the platelet counts had
increased to levels above that of basal values (316 ± 75.54),
(P = 0.013 as determined by ANOVA). Upon further
analysis, pairwise comparison testing showed significant
differences between baseline and day 3 postoperative
(P = 0.04). With regards to the platelet counts and TKR
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(Figure 1), these decreased from baseline (296 ± 83.97),
during 5 (272 ± 76.64), 15 (259 ± 89.67) minutes reper-
fusion and day 1 postoperative (204 ± 48.23). By day 5
(328 ± 75.70) postoperatively the platelet counts had in-
creased to levels above that of basal values, although
these did not reach statistical significance (P = 0.06, as
determined by the Friedman test).
D-dimer concentration
This parameter was measured as a marker of coagula-
tion activity (Figure 2). Although no significant changes
were observed in the D-dimer concentration (ng/ml) fol-
lowing THR surgery (P = 0.323, as determined by the
Friedman test), a trend of increasing D-dimer concen-
tration from baseline (3050.36 ± 2402.66), during day 1
(4026.01 ± 2030.04), and peaking at day 3 postoperative,
was seen (6510.60 ± 5548.89). At day 5 (2207.56 ± 583.46)
postoperative the D-dimer concentration decreased to
levels lower than that of basal values.
With regards to TKR surgery, significant changes were
observed in D-dimer concentrations (P = 0.009, as deter-
mined by the Friedman test). D-dimer concentrations
increased from baseline (754.59 ± 517.54), during 5
(2005.79 ± 1565.17) and 15 (2789.55 ± 2747.24) minutes re-
perfusion, and peaked at day 1 (4899.40 ± 2490.35) postop-
eratively. The concentration decreased at day 3 (2243.83 ±
678.45) and day 5 (2709.85 ± 323.29) postoperatively,
although it remained at a higher level to that of basal
values (three-fold). Upon further analysis, the Wilcoxon
test showed significant differences between baseline and
day 1, day 3 and day 5 postoperatively (P ≤ 0.05).
Effect of total hip replacement and total knee
replacement on non-specific inflammatory markers
Erythrocyte sedimentation rate
Samples were collected prior to and following THR and
TKR surgery, and the ESRs were analyzed using the
Westergren method (mm/hr). This parameter was
measured as a marker of non-specific inflammation
(Figure 3). Following THR surgery, significant changes
were seen in the ESRs (P = 0.001, as determined by
ANOVA). ESRs increased from baseline (23.80 ± 7.22),
and at day 1 (38.80 + 18.43) and day 3 (67.00 ± 29.69),
peaking at day 5 (82.40 ± 23.30) postoperatively. Upon
further analysis, pairwise comparison testing showed
significant differences between baseline and day 5
(P = 0.027) postoperatively.
With regards to TKR surgery, significant changes
were observed in ESRs (P = 0.002, as determined by the
Friedman test). These values increased from baseline
(16.75 ± 15.69), during 5 (17.75 ± 16.42) and 15 (22.00 ±
18.92) minutes reperfusion and at day 1 (44.50 ± 21.29)
postoperative, peaking at day 3 (94.00 ± 24.49) postoper-
atively. ESRs decreased very slightly at day 5 (91.75 ±
26.51) postoperatively, and remained at a higher level
than those of basal values (five-fold). Upon further
analysis, the Wilcoxon test showed no significant dif-
ferences between the measured parameters.
Figure 1 Effect of THR and TKR surgery on platelet counts. The points represent mean ± SD. P = 0.013 (n = 5), as determined by ANOVA
(THR). Upon further testing, the pairwise comparison showed significant differences between baseline vs day 3 postoperative (*P = 0.04). ANOVA,
analysis of variance; SD, standard deviation; THR, total hip replacement; TKR, total knee replacement.
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C-reactive protein
The results are expressed as ng/ml and represent
the changes in CRP concentration (a non-specific
marker of inflammation) following THR and TKR
surgery (Figure 4). Following THR surgery significant
changes were seen in CRP concentrations (P ≤ 0.001,
as determined by ANOVA). CRP concentrations
increased from baseline (4.18 ± 2.03), at day 1 (43.14
± 25.83) and peaking at day 3 (101.24 ± 22.48) post-
operatively. CRP concentration decreased towards
basal levels at day 5 (58.22 ± 24.28) postoperatively,
although remained at a higher level to those of basal
values (14 fold). Upon further analysis, pairwise
comparison testing showed significant differences
Figure 2 Effect of THR and TKR surgery on D-dimer concentration. The points represent median ± SD, P = 0.009 following TKR surgery, as
determined by the Friedman test. *P ≤ 0.05 baseline vs day 1, day 3 and day 5 postoperative for TKR surgery, as determined by the Wilcoxon test,
n = 10. ANOVA, analysis of variance; SD, standard deviation; THR, total hip replacement; TKR, total knee replacement.
Figure 3 Effect of THR and TKR surgery on ESR. The points represent mean or median?±?SD, P?=?0.05 for both THR and TKR surgery, as
determined by ANOVA and the Friedman tests, respectively. Baseline vs day 5 postoperative for THR (*P?=?0.027), as determined by pairwise
comparison testing, n?=?10. ANOVA, analysis of variance; SD, standard deviation; THR, total hip replacement; TKR, total knee replacement.
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between baseline vs day 3 (P = 0.004) and day 5
(P = 0.048) postoperatively.
With regards to TKR surgery, significant changes were
observed in CRP concentrations (P ≤ 0.001, as deter-
mined by the Friedman test). CRP concentrations in-
creased from baseline (0.62 ± 0.50), during 5 (1.76 ±
1.24) and 15 (3.06 ± 1.78) minutes reperfusion and at
day 1 (50.64 ± 23.19) postoperative, peaking at day 3
(131.26 ±43.78) postoperatively. The CRP concentration
decreased at day 5 (82.68 ± 38.86) postoperatively, al-
though it remained at a higher level than those of basal
values (136 fold). Upon further analysis, the Wilcoxon
test showed significant differences between baseline and
15 minutes reperfusion, day 1, day 3 and day 5 postoper-
atively (P ≤ 0.05).
Effect of THR and TKR on clinical outcome measures
Blood transfusion
Patients received transfusions of standard National Health
Service Blood and Transplant (UK) ABO/rhesus compat-
ible donor red blood cell units following surgery at the
orthopaedic surgeon’s discretion. Following THR surgery,
patient 1 received two units of cross-matched red blood
cells (Figure 5). Patients 2 to 5 did not require any blood
transfusion following THR surgery. With regard to TKR
surgery, patients 1 and 3 required no blood transfusions.
Patient 2 received two units of cross-matched blood follow-
ing surgery. Patients 4 and 5 received 4 and 6 units of
cross-matched blood, respectively. None of the patients re-
ceived platelet transfusions.
Oedema (total knee replacement only)
Postoperative oedema (knee swelling) was assessed by
measuring girth size 10 cm from the tibial tuberosity
(the bony prominence on the upper shinbone) and was
performed on TKR patients only (Figure 6). Following TKR
surgery, oedema was demonstrated to increase significantly
(P = 0.003, as determined by ANOVA). Oedema in TKR
patients increased from baseline (36.2 cm), at day 1 (39.1
cm), peaking at day 3 postoperative (40 cm). By day 5, post-
operative fluid retention levels had reduced slightly (39.6
cm), although they still remained higher than those of
basal values. Upon further testing by Tukey’s pairwise
comparisons, significant differences between baseline
and day 1 postoperative (P = 0.002), day 3 postoperative
(P=0.004) and day 5 postoperative (P= 0.045) were observed.
Postoperative pain
It can be appreciated that the assessment of pain is diffi-
cult, owing to its subjective nature. However, pain was
monitored during this study and was assessed by a point
scoring system routinely used by the nursing and medical
staff at the North Wales Medical Centre (Figure 7). Fol-
lowing THR surgery postoperative pain significantly in-
creased (P = 0.020, as determined by the Friedman test).
Pain increased from baseline (pain score, 1) and peaked at
day 1 (mean pain score, 2.2) postoperative, which was
demonstrated to be mild pain. By day 3 (mean pain score,
2) and day 5 (mean pain score, 1.6) postoperative, the
mean pain scores decreased although still remained
higher to those of basal values. Upon further testing using
Figure 4 Effect of THR and TKR surgery on CRP concentration. The points represent mean or median ± SD, P≤ 0.001 for both THR and TKR
surgery, as determined by ANOVA and the Friedman test respectively. *P≤ 0.05 Baseline vs day 3 and day 5 postoperative for THR (pairwise
comparison), and baseline vs 15 minutes reperfusion, day 1, day 3 and day 5 postoperatively for TKR surgery (Wilcoxon), n = 10. ANOVA, analysis
of variance; SD, standard deviation; THR, total hip replacement; TKR, total knee replacement.
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the Wilcoxon test, there were significant differences be-
tween baseline vs day 3 postoperative (P = 0.025).
Following TKR surgery postoperative pain significantly
increased (P = 0.012, as determined by the Friedman test).
Pain increased from baseline (mean pain score, 1) and
during day 1 (mean pain score, 2.2), and peaked at day 3
(mean pain score, 2.8) postoperative, when pain was
scored as mild to moderate. By day 5 (mean pain score, 2)
postoperative, the mean pain scores decreased although
they still remained higher than those of basal values, with
patients experiencing mild pain overall. Upon further test-
ing using the Wilcoxon test, there were significant differ-
ences between baseline vs day 1 postoperative (P = 0.025)
and day 3 postoperative (P = 0.034).
Figure 5 Effect of THR and TKR surgery on total red cell units transfused. Transfusion of ABO and rhesus compatible red blood cells, n = 10.
THR, total hip replacement; TKR, total knee replacement.
Figure 6 Effect of THR and TKR surgery on oedema. Measurement of fluid retention (knee swelling) was performed by measuring girth size
10 cm from the tibial tuberosity (the bony prominence on the upper shinbone (tibia)). The points represent mean ± SD, P = 0.003 as determined
by ANOVA. Baseline vs days 1 (*P = 0.002), 3 (*P = 0.004) and 5 (*P = 0.045) postoperative, n = 5 (five TKR patients). ANOVA, analysis of variance; SD,
standard deviation; THR, total hip replacement; TKR, total knee replacement.
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Aural temperature
Postoperative pyrexia was diagnosed when the aural body
temperature was at, or higher than 37.5°C by means of an
auricular thermometer (Figure 8). The value of 36.8°C ±
0.7°C was considered to be the normal aural temperature.
Following THR surgery the mean aural temperature in-
creased from baseline (36.7°C), during day 1 postoperative
(37.0°C) and peaking at day 3 (37.1°C) postoperatively. By
day 5 postoperative the aural temperatures had returned
towards basal values (36.7°C).
Figure 7 Effect of THR and TKR surgery on postoperative pain. Postoperative pain was measured by a point scoring system with 1
indicating no pain; 2, mild pain; 3, moderate pain and 4, severe pain. The points represent median ± SD, as determined by the Friedman test
(P = 0.020 THR, P = 0.012 TKR). Baseline vs day3 (*P = 0.025) postoperative TKR; Baseline vs days 1 and 3 (*P = 0.025 and *P = 0.034, respectively)
postoperative TKR, n = 10. SD, standard deviation; THR, total hip replacement; TKR, total knee replacement.
Figure 8 Effect of THR and TKR surgery on aural temperature. Pyrexia (fever) was monitored by measurement of aural temperatures, with
pyrexia diagnosed when the temperature was at, or higher than, 37.5°C. The points represent mean ± SD, P ≥ 0.05 for THR and TKR, n = 10. SD,
standard deviation; THR, total hip replacement; TKR, total knee replacement.
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Following TKR surgery, the mean aural temperature in-
creased from baseline (36.2°C) and peaked at day 1 (37.0°C)
postoperatively. By day 3 (36.9°C) and day 5 (36.8°C) post-
operative, the aural temperatures had returned towards
basal values. Although a trend of increasing pyrexia follow-
ing both THR and TKR orthopaedic surgeries was ob-
served, these did not reach statistical significance (P = 0.372
THR surgery, as determined by the Friedman test, and
P = 0.146 TKR, as determined by ANOVA).
During this study four patients (two THR and two
TKR) developed postoperative fevers (individual patient
data not shown).
Wound infection
Wound swabs were collected and assessed for evidence of
infection at the site of surgery (Table 1). They were collected
before and after THR and TKR surgery (day 3 postopera-
tive), and were assessed at the Microbiology Laboratory at
Glan Clwyd Hospital, North Wales (UK). They were incu-
bated for 48 hour periods on blood agar, MacConkey agar,
anaerobic medium, and Staphylococcus and Streptococcus se-
lective agar plates and were all negative.
Discussion
An important aspect of this study was the evaluation of
selective biomarkers and clinical outcome measures,
which would provide a better understanding of the post-
operative course following elective lower limb ortho-
paedic surgery.
Results from the study demonstrated evidence of de-
creasing platelet concentration following THR surgery.
This surgery resulted in a decrease in platelet counts
(day 1 and day 3 postoperatively), with the platelet con-
centrations increasing to that above basal values (pre-
operatively) at day 5 postoperatively (P ≤ 0.05). Similar
trends were observed following TKR surgery. The results
obtained during this study build on previous work by
Høgevold et al. [3], which provided evidence of leucocyt-
osis following THR surgery, and provides further evidence
of thrombocytic involvement during the postoperative
course. Our findings also complement work by Harr et al.
[4] that demonstrated increased platelet counts and
subsequent hypercoagulability in other surgical settings. It
may therefore be inferred that following long-bone surgi-
cal intervention there is a systemic response resulting in
leucocytosis and thrombocytosis. These changes are pos-
sibly due to increased bone marrow turnover, which has
resulted from THR and TKR surgery procedures, postop-
erative wound and tissue repair or, probably, a combin-
ation of these contributing factors.
Concentrations of D-dimer were measured as a marker
of coagulation activity. Specifically, D-dimer concentration
in the plasma was affected following TKR (P ≤ 0.05) sur-
gery. This increased from baseline (preoperatively) up to
day 1 postoperatively. Changes in D-dimer concentrations
demonstrate an increased coagulation activity following
surgery, with a possible explanation for these changes be-
ing that TKR surgery has an intrinsic effect on normal
homeostasis, resulting in changes in the coagulation path-
ways; this may lead to postoperative complications, such
as deep vein thrombosis. Muñoz et al. [16] have reported
that D-dimer levels increased on day 1 post TKR surgery
and remained elevated at day 30 postoperative. They re-
ported that increased D-dimer levels following TKR sur-
gery do induce changes in coagulation activity, with these
changes not being modified by either allogenic, unwashed
drainage or no blood transfusion. In agreement with
Muñoz et al. [16], this study demonstrates evidence of in-
creased coagulation activity following TKR surgery, and
provides further evidence that similar yet insignificant
changes were observed following THR surgery.
This study assessed changes in inflammatory markers
following THR and TKR surgery. It was demonstrated
that there was a significant effect of surgery on the CRP
level and ESR, which were indicative of an increased sys-
temic inflammatory response during the acute phase post-
surgery. The results are in accordance with Margheritini
et al. [8] who demonstrated an increase in both CRP levels
and ESR (peaking between day 3 and day 7 post-surgery),
following uncomplicated anterior cruciate ligament recon-
struction. This study illustrates that similar patterns were
observed, demonstrating an increased inflammatory re-
sponse following THR and TKR surgery, peaking at day 3
postoperative with respect to CRP levels. However, ESR
values peaked at day 5 postoperative following THR and
TKR. With respect to measurement of both these
Table 1 Effect of THR and TKR surgery on wound infection
THR (preoperatively) THR (day 3 postoperatively) TKR (preoperatively) TKR (day 3 postoperatively)
Blood agar Negative Negative Negative Negative
MacConkey Negative Negative Negative Negative
Anaerobic medium Negative Negative Negative Negative
Staphylococcus selective agar Negative Negative Negative Negative
Streptococcus selective agar Negative Negative Negative Negative
Wound swabs were collected and assessed for evidence of infection at the site of surgery. Swabs were collected pre and post THR and TKR surgery (day 3
postoperative). Swabs were incubated for 48 hour periods on blood agar, MacConkey agar, anaerobic medium and agar selective for Staphylococcus
and Streptococcus.
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parameters, which are considered to be sensitive non-
specific markers of inflammation, it was demonstrated
that both tests were effective methods of measuring
acute inflammatory response post-surgery. However, it
may be considered that measuring CRP is more efficient
than ESR, in that CRP levels increased dramatically up
to day 3 postoperative, showing a higher fold increase,
whereas the ESR displayed a gradual increase during
this period. A possible explanation for the increase in
ESR is that rouleaux formation and red cell clumping
are mainly controlled by the concentrations of fibrino-
gen and other acute-phase proteins, such as CRP, which
may play an intrinsic role that affects the ESR results
observed postoperatively. This suggests that CRP levels
subsequently affect ESR. Furthermore, the finding that
the increase for CRP was greater than that of ESR sug-
gests that CRP concentration is a more sensitive marker
of inflammation. This was supported by the finding that
CRP levels dropped at day 5, whereas ESRs remained
high at this time point. Our results are in general accord
with White et al. [17], who demonstrated an increase in
CRP on the second day post TKR; our study demon-
strated that CRP levels peaked at day 3 postoperatively
(following THR and TKR surgery), with the CRP values
following TKR surgery being slightly greater than those
of THR at this time. Results from this study also com-
plement findings published by Orrego et al. [18], who
demonstrated that CRP levels fluctuated after various
elective orthopaedic surgical procedures, with max-
imum values being observed between the second and
third postoperative day. The elevated levels of CRP ob-
served may be due to the release of pro-inflammatory
cytokines, such as interleukin-1 and interleukin-6 from
the activated cells in response to surgery and inflamma-
tion [19,20].
With regards to the clinical outcome measures, various
parameters were measured prior to and following THR
and TKR surgery. Assessment of the number of red cell
units administered to each patient following THR and
TKR surgery demonstrated that patients scheduled for
TKR surgery required more blood (packed red cells) post-
operatively than THR patients. In agreement with Sakić
and Sakić [9], the present study demonstrates that the
number of red cell units transfused per patient (if any) is
determined based on routine clinical and laboratory find-
ings postoperatively, as performed by consultants, medical
officers and nursing staff. However, it is important to note
that for the patients who required blood transfusions dur-
ing these clinical studies, the introduction of foreign ma-
terial, in the form of packed red blood cells, to the
peripheral blood system may have an effect on the bio-
logical markers measured and the outcome of some of the
results obtained. Nevertheless, to fully appreciate the sys-
temic complication that blood transfusion may have had
on the biological markers measured in this study, further
independent studies would need to be performed, to com-
pare directly the effects of surgery on the various bio-
logical markers for those patients who did and did not
receive blood transfusions. During this pilot study, the
measured parameters did not differ between patients re-
ceiving blood and those without.
Measurement of oedema (swelling of the knee) following
TKR surgery was performed by measuring girth size 10 cm
from the tibial tuberosity. A previous study has demon-
strated that the loss of knee-extension strength following
total knee arthroplasty is related to increased knee swelling
[21]. In agreement with others [21], results from our inves-
tigations demonstrated that, following TKR surgery,
oedema was most prevalent at day 3 postoperative (P ≤
0.05). Interpretation of these results may suggest that at
day 3 postoperative the inflammatory response during the
acute phase post-surgery may have been at its highest,
resulting in local oedema around the surgical area. With re-
spect to oedema, it can be appreciated that anything that
increases osmotic pressure outside blood vessels (for ex-
ample inflammation), or reduces osmotic pressure in the
blood (states of low plasma osmolality) will cause oedema,
and this may suggest that some of the inflammatory
markers measured during these studies could relate to this.
Postoperative pain and management has been reported
by others previously [12], and during this study analge-
sics were prescribed as standard treatment postoperative
to minimize any pain and discomfort following surgery.
However, results obtained from this study demonstrated
that, following THR and TKR, most pain was experi-
enced at day 3 regardless of prescribed analgesics to help
minimize any pain. Postoperative pyrexia (fever) was di-
agnosed when measurement of the aural temperature
was at, or higher than 37.5°C. During this study four pa-
tients (two THR and two TKR) developed postoperative
fevers (data not shown), although there was no overall
significant temperature increase following THR and
TKR surgery. Although, previous studies have been per-
formed to investigate fevers and orthopaedic surgery
[10-13], this study confirmed that developing fevers
post-surgery is still a postoperative complication to be
considered and treated by medical officers and surgeons.
Interestingly, the fevers that developed during the
current study occurred without any infection, which
may suggest that this may be a normal physiological re-
sponse to surgery in certain patients.
With regards to postoperative infection, none of the pa-
tients involved during this study developed wound infec-
tion. Therefore, infection probably does not explain the
changes in biological markers that have been found. The
orthopaedic surgeons involved in the study (and as part of
standard practice) routinely administered antibiotics to all
their patients pre-surgery and post-surgery to minimize
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any risk of infection and the potential of developing post-
operative sepsis (a systemic response to infection).
Although monitoring patients to assess for any signs of
postoperative complications was performed, it was felt
that in order to achieve a more accurate understanding of
the effects of THR and TKR surgery on these clinical pa-
rameters, a more detailed clinical assessment would be re-
quired. It should also be appreciated that for those
patients requiring TKR surgery, an application of a tourni-
quet was employed. TKR patients were subjected to long
periods of ischaemia (94 ± 7.47 minutes), with tourniquet
pressure being set as a standard up to 350 mmHg. We
have previously shown the effects of ischaemia and reper-
fusion on non-surgical models, but the main purpose of
this study was to determine the effects of THR and TKR
surgery on various biological markers, and not to develop
a clinical model of ischaemia-reperfusion injury [22].
Although it was interesting to investigate clinical out-
come measures during this study, the primary objective
was to investigate the effects of surgery on various bio-
logical markers. Despite the fact that some interesting clin-
ical outcome observations were made as a secondary
measure, further studies would have to be performed to
fully explore any relationships between the biological
markers measured and the clinical outcome measures
assessed. However, in principle this study provides a sound
platform to further investigate these possibilities and to try
to determine any links between the laboratory data and
those obtained from the clinical outcome measures.
In summary, it is proposed that changes in the mea-
sured parameters during this study may not be due to
a single factor, but due to a number of factors that
may result following surgery such as tissue damage,
wound repair, introduction of foreign material (for ex-
ample, prosthesis or red blood cells via blood transfu-
sion) and ischaemia-reperfusion injury during joint
replacement surgery.
Conclusions
It appears that changes in biological markers following
THR and TKR surgery followed a similar trend. Most
noticeable changes in biological markers occur during
days 1 to 3 postoperatively for both THR and TKR
surgery, and these may have an effect on some of the
clinical outcomes, such as oedema, pyrexia and post-
operative pain that develop post-surgery. This study
may therefore have clinical implications for under-
standing the postoperative course following lower limb
orthopaedic surgery, and may help clinicians in plan-
ning their postoperative management and patient care.
The study may also provide an opportunity to highlight
potential points of therapeutic intervention, which ultim-
ately promote patient recovery following major ortho-
paedic surgery.
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